Literature DB >> 9820997

Small ventricular septal defects in adults.

U Neumayer1, S Stone, J Somerville.   

Abstract

AIMS: To establish the frequency of complications in adults with small ventricular septal defects, which have not undergone surgery. METHODS AND
RESULTS: One hundred and eighty-eight adults aged 17-72 (mean, 29.2) years with a small ventricular septal defect were studied. They were referred to a national cardiac centre (National Heart Hospital) and specialized grown-up congenital heart unit. One hundred and thirty-eight were examined in 1994-95. Fifty patients (26.6%) had additional cardiovascular lesions, most commonly a bicuspid aortic valve and/or coarctation. Spontaneous closure occurred in 19 (10%) between the age of 17 and 45 (mean, 27) years. Twenty-one (11.2%) had infective endocarditis. Aortic regurgitation developed in 37 (19.7%) patients; it was severe in nine. Atrial arrhythmias (supraventricular tachycardia or atrial fibrillation) occurred in 12 patients. In four patients, atrial fibrillation produced severe right-sided congestion with a left ventricular to right atrial shunt and haemodynamic features suggesting 'restrictive cardiomyopathy'. Four patients had ventricular arrhythmia. Disproportionate left ventricular enlargement on echocardiography and/or chest radiography was present in 26 (13.8%) without lesions to account for it.
CONCLUSIONS: Eighty nine patients (47%) aged 17-44 (mean, 26.8) years had no complications through many years, while spontaneous closure occurred in 19 (10%) during adulthood. Forty-six (25%) had serious complications: infective endocarditis (11%), progressive aortic regurgitation (5%), age-related symptomatic arrhythmias (8.5%) and atrial fibrillation the commonest. Accepting that there may be a referral bias for those with complications, the course of a small ventricular septal defect is not necessarily benign during adult life.

Entities:  

Mesh:

Year:  1998        PMID: 9820997     DOI: 10.1053/euhj.1998.1083

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  20 in total

1.  Ventricular Septal Defect.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-12

Review 2.  Challenges in the care of adult patients with congenital heart defects.

Authors:  Gary D Webb
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

3.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions.

Authors:  Candice K Silversides; Annie Dore; Nancy Poirier; Dylan Taylor; Louise Harris; Matthias Greutmann; Lee Benson; Helmut Baumgartner; David Celermajer; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 4.  A review of isolated muscular ventricular septal defect.

Authors:  Toshiharu Miyake
Journal:  World J Pediatr       Date:  2019-07-25       Impact factor: 2.764

5.  Survival with congenital heart disease and need for follow up in adult life.

Authors:  C Wren; J J O'Sullivan
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 6.  A review of spontaneous closure of ventricular septal defect.

Authors:  Jun Zhang; Jong Mi Ko; Joseph M Guileyardo; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

Review 7.  Valvular heart disease in congenital heart disease: a narrative review.

Authors:  Joshua M Saef; Joanna Ghobrial
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

8.  A ventricular septal defect with a giant appendiform aneurysm of the membranous septum.

Authors:  M A Cozijnsen; L Cozijnsen; A C P Maas; M Bakker-de Boo; B J Bouma
Journal:  Neth Heart J       Date:  2013-03       Impact factor: 2.380

9.  Aneurysm of the ventricular membranous septum: serial echocardiographic studies.

Authors:  T Miyake; T Shinohara; Y Nakamura; T Fukuda; H Tasato; K Toyohara; Y Tanihira
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

Review 10.  Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Authors:  Nazzareno Galie; Alessandra Manes; Massimiliano Palazzini; Luca Negro; Alessandro Marinelli; Simona Gambetti; Elisabetta Mariucci; Andrea Donti; Angelo Branzi; Fernando M Picchio
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.